ncRNA name
CircDOCK1
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-339-3p/IGF1R
Cancer name
Osteosarcoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis
Tissue resource
osteosarcoma tissues and paracancerous tissues
human normal osteoblastic cell lines hFOB 1.19
human osteosarcoma cell lines MG63
human osteosarcoma cell lines SaOS-2
human osteosarcoma cell lines U2OS
human osteosarcoma cell lines HOS
Experiment
None
Institute
Cancer Hospital of China Medical University
the Cell Bank of the Chinese Academy of Sciences
Country
China
China
Continent
Asia
Asia